Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer

MLA

Jun Qi, et al. “Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer.” Cancer Research, vol. 80, Sept. 2020, pp. 3556–67. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e1e7f4c0dc9fb22a749a5fe0dff251d2&authtype=sso&custid=ns315887.

APA

Jun Qi, Michela Ranieri, Wai-Lung Ng, John T. Poirier, Alireza Khodadadi-Jamayran, Fei Li, Qingyuan Huang, Vladislav O. Sviderskiy, Hon-Cheong So, Shuai Li, Kate E.R. Hollinshead, Paula Zouitine, Kwok-Kin Wong, Mousheng Xu, Troy A. Luster, Kai Zhao, Richard Possemato, Wei Wang, Yuanwang Pan, … Hua Zhang. (2020). Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer. Cancer Research, 80, 3556–3567.

Chicago

Jun Qi, Michela Ranieri, Wai-Lung Ng, John T. Poirier, Alireza Khodadadi-Jamayran, Fei Li, Qingyuan Huang, et al. 2020. “Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer.” Cancer Research 80 (September): 3556–67. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e1e7f4c0dc9fb22a749a5fe0dff251d2&authtype=sso&custid=ns315887.